Managed Care



March 2012

Just about everyone except the patient is offering some kind of incentive to do something, but beware of unintended, not to say unwanted, outcomes: the notorious perverse incentive
Frank Diamond
Community Care of North Carolina says it has data on decreased hospital utilization and ER visits
Joseph Burns
A national survey finds big gaps in knowledge about how to manage these costly drugs
Cheryl Larson ; Margaret Rehayem ; Larry Boress ; F. Randy Vogenberg
Employers believe in this hybrid approach. Is it time for medical insurers to look at it carefully?
Carol Milano
The program showed significant improvements in all diabetes and hypertension-related clinical measures
Debra Wertz, PharmD ; Likun Hou, MS ; Andrea DeVries, PhD ; Leon Dupclay Jr., PharmD, PhD ; Frannie McGowan, PharmD, CDE

Legislation & Regulation
The new system is supposed to have transparent pricing, but some say it is susceptible to manipulation, which was AWP’s downfall
John Carroll
Medication Management
Developers make progress with genetic markers aimed at improving drug response
Thomas Reinke
Tomorrow's Medicine
The FDA will make a final determination on regulations intended to permit the sale of ‘follow-on’ biologics
Thomas Morrow, MD


4th Partnering With ACOs Summit Los Angeles, CA October 27–28, 2014
PCMH & Shared Savings ACO Leadership Summit Nashville, TN November 3–4, 2014
2014 Annual HEDIS® and Star Ratings Symposium Nashville, TN November 3–4, 2014
Medicare Risk Adjustment, Revenue Management, & Star Ratings Fort Lauderdale, FL November 12–14, 2014
World Orphan Drug Congress Europe 2014 Brussels, Belgium November 12–14, 2014
Healthcare Chief Medical Officer Forum Alexandria, VA November 13–14, 2014
Home Care Leadership Summit Atlanta, GA November 17–18, 2014
HealthIMPACT Southeast Tampa, FL January 23, 2015